A company that is working to help blind people regain functional vision even after extensive damage to the eye or optic nerve
Phosphoenix has raised €1.3M across 2 funding rounds from 9 investors, most recently a round in Sep 2026. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 21 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
